Accounting Lead
embecta
Accounting Lead
embecta
Manufactures insulin delivery devices worldwide
embecta is a global medical device company with a 100-year legacy in insulin delivery and diabetes care. Driven by innovation, purpose, and a commitment to improving lives, we are expanding our portfolio of solutions to serve even more patients, healthcare providers, and communities around the world.
Job Description
A hands-on senior accounting personnel to manage the outsourced finance and accounting functions for our entity in India. In this role, he/she will be responsible for working closely with our outsourcing partner, Genpact to ensure all transactional activities and treasury related tasks are accurately and efficiently performed. He/She will also be responsible for managing the local regulatory reporting and other statutory reporting and foreign currency reporting. He/She will report to the Associate Director, Controller Asia and Greater China and will work closely with cross-functional teams.
Key Responsibilities:
Financial Operations and Controllership
Financial Reporting
Treasury and Cash Management
Order-to-Cash and Working Capital Management
Procure-to-Pay and Operational Finance
Tax and Statutory Compliance
Audit and Internal Controls
Systems and Process Improvement
Stakeholder and other support
#LI-AH1
embecta is an Equal Opportunity/Affirmative Action Employer. We do not unlawfully discriminate on the basis of race, color, religion, age, sex, creed, national origin, ancestry, citizenship status, marital or domestic or civil union status, familial status, affectional or sexual orientation, gender identity or expression, genetics, disability, military eligibility or veteran status, or any other protected status.
Embecta designs, manufactures, and sells insulin delivery devices such as pen needles, insulin syringes, and safety injection devices for diabetes patients around the world. Its products are used to inject insulin and include disposable components like Nano and Ultra-Fine needles, with a tubeless insulin patch pump once pursued but later refocused on core injection devices. The company differentiates itself as a dedicated diabetes injection devices supplier with a global manufacturing footprint and an established distribution network, originating as a BD spin-off. Embecta aims to grow through strategic expansion, including an announced plan to acquire Owen Mumford to broaden into drug-delivery platforms beyond diabetes.
Explore more opportunities at embecta